Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, — La Crosse, Wisconsin

Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, is a clinical research site located in La Crosse, Wisconsin, United States 54601.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Kyowa Kirin Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in La Crosse

Browse all research sites in Wisconsin · View every site in La Crosse

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001,?

Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, conducted?

Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, accredited by Crixeo Clinical Trials?

Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Gundersen Clinic Center for Cancer and Blood Disorders, 1900 South Ave, EB2-001,?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.